Monday 16 January 2017 The one stop source for free breaking news, expert analysis, and videos on AIM and LSE listed shares


Optiobiotix – Top Slice

By James Parter | Sunday 23 November 2014


Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I tipped Optibiotix (OPTI) at 10p just three weeks ago and the shares are now 21p. Normally I’d say sell the lot and thanks for a 110% gain but on this occasion…

I note how bullish the team at HotStockRockets is (HERE) and I know Tom W is a big holder and reckons the shares are going to whoosh and soon! Bearing that in mind I reckon that you should sell half and then let the rest run – effectively top slicing means that you are in for free.

Watch out for my next biopharma tip out soon. I'm just waiting for the stars to align.

 


Filed under:


Never miss a story.




This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.


More on OPTI


Comments

7 comments

  1. Hello should we get emailed updates as subscribers or are we supposed to log in all the time to check for updates? Appreciate it if you could let me know. Thank you. J

  2. Top sliced this one a little early on Thursday afternoon (@ 18.50 sell, bought @ 9.25), missing out on Fridays rise. Although this is a promising company, a 100% share price increase requires some banking of profits. Shares never go up in a straight line!

    And it’s like you say in your piece, anything that happens from here on in is for free!!

  3. Hi

    Hot stock rockets sends out alerts on updates. HSR DOES NOT advise top slicing Opti we think JP is 100% wrong here.

    On SP if you add a stock to your portfolio on this site ( button undernearth an article) you get an alert

    t

  4. Oh dear, that knocks my strategy out the window, I have been buying OPTI from 9.2p to 13.6p, and taking into account some would take profits, intended buying more if the price dipped and started to rise again. Been doing the same with SGI as well. I think I will carry on until I see a reason not to.

    I never average down now, I used to but you can bet your life it carries on falling., Likewise the number of shares I have sold to early far outnumbers those I sold to late.

  5. don’t really think you should be advising ppl not to topslice a 100%gain just because youre worried about your large holding!

  6. Paul

    No I am advising against Top slicing because the shares are going to go up. I would like our readers to make even more money on this fabulous share tip.

    The RMPC holding is only paper now & we can only sell when we have given readers 24 hrs notice so they can sell first. So your point is kind of irrelevant. If I wanted us to sell I would have actually advised a top slice. I dont so didnt.

    Best wishes

    T

  7. James

    As a punter who has been moving their portfolio to a more defensive stance, I await your new bio-pharma tip, with great interest.

    Happily followed your and SharePhrophets tips into Optibiotix @ 9.45p and Premaitha @ 13.62p. Also bought into Sinclair is Pharma, Tristal and Ekf Diagnostics a couple of weeks ago, considering them decent punts with strong management, exciting products – development and large holdings held by institutional investors.

    There are several others that catch my eye, but will now hold off until you go public on your offering.


Enter your comment below. Fields marked * are required. You must preview your comment first before finally posting.




Site by Everywhen